Suppliers / Shandong New Time Pharmaceutical

Shandong New Time Pharmaceutical

China Updated 9 July 2026

Shandong New Time Pharmaceutical is an API and finished-dose manufacturer based in China. It holds 34 active US drug master files and 8 valid CEPs. Its filings concentrate with US FDA, TMDA (TZ) and EFDA (ET). Its GMP standing is certified by EMA, MFDS (Korea) and TMDA (TZ), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 9 July 2024 as VAI.

34
active US DMFs
8
valid CEPs
3
registered plants 1 with an FDA FEI number
20
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 9 July 2024 VAI US FDA
  • 11 May 2018 VAI US FDA
  • 25 March 2016 VAI US FDA
  • 23 August 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SHANDONG, China Not on file
Linyi, China Not on file
China, China 3006704412

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 14 1
TMDA (TZ) 2 1
EFDA (ET) 1 None
UZPHARM (UZ) 1 None
MINSA (CR) 1 None
JFDA (JO) 1 None
EMA None 3
MFDS (Korea) None 2
ANVISA (Brazil) None 1

Questions about Shandong New Time Pharmaceutical

Does Shandong New Time Pharmaceutical hold a US DMF or a CEP?
Shandong New Time Pharmaceutical holds 34 active US drug master files and 8 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Shandong New Time Pharmaceutical FDA-registered?
One site operated by Shandong New Time Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Shandong New Time Pharmaceutical's last inspection go?
The most recent inspection on record closed on 9 July 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does Shandong New Time Pharmaceutical manufacture?
3 registered sites are on record, in China (Shandong, Linyi and China). Every site is listed on this page with the register it came from.
What does Shandong New Time Pharmaceutical make?
30 molecules are on record against Shandong New Time Pharmaceutical, including Isoflurane, Potassium Clavulanate, Sevoflurane and Clavulanic Acid. Each links through to that molecule's full manufacturer list.
Which regulators recognise Shandong New Time Pharmaceutical's GMP?
Current GMP certificates are on record from EMA, MFDS (Korea), TMDA (TZ), US FDA and ANVISA (Brazil). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong New Time Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 2 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 9 July 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates